Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Control of TH17 cells occurs in the small intestine.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS.
Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson's disease - what is the evidence?
[Optic neuropathy and meningioma: A diagnostic trap.]
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Review: the role of vitamin D in nervous system health and disease.
Proteomic analysis of the anti-inflammatory action of minocycline.
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
A biopsychosocial model of resilience for multiple sclerosis.
JCV test stratifies PML risk in antibody-positive MS
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.
Disc swelling and mild initial visual acuity loss predict a better short-term visual acuity outcome in bilateral acute optic neuritis.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Diffusion Tensor Imaging (DTI) - A New Imaging Technique Applyed in Multiple Sclerosis.
Pages
« first
‹ previous
…
168
169
170
171
172
173
174
175
176
…
next ›
last »